Please login to the form below

Not currently logged in
Email:
Password:

NHS’ Jim Easton reportedly joining Care UK

HSJ says he has resigned as director of transformation at NHS Commissioning Board

Jim Easton Care UKThe NHS Commissioning Board's director of transformation Jim Easton is set to move from his public sector position to join private healthcare provider Care UK as managing director.

The Health Service Journal (HSJ) reports Easton has resigned his NHS position, and there will now be a process of negotiation before the move is formally agreed.

Easton, who also serves as Department of Health's (DH) national director for improvement and efficiency, has been one of the leading voices in championing the QIPP agenda, which aims to implement an ideology of quality, innovation, productivity and prevention throughout NHS care in England and Wales in order to meet efficiency-saving demands of £20bn.

He joined the NHS Commissioning Board following its creation to oversee regional clinical commissioning groups and provide national standards and accountability for commissioning services.

If he does depart it will damage confidence in the NHS' ability to implement the intentions of QIPP and could possibly give further ammunition to critics of the NHS reforms, who already see them as paving the way for privatisation of the English healthcare system.

An NHS Commissioning Board spokesperson told the HSJ: “We can confirm that Jim Easton has been approached about a job opportunity by an organisation in the independent health sector.

“Because this would be an outside appointment, it is subject to approval in line with the business appointment rules for senior Department of Health staff moving to new roles in the independent sector."

Easton has a rich history in the NHS, having served as chief executive of the strategic health authority NHS South Central and chief executive officer of York Hospitals NHS Foundation Trust.

He has also developed links with the pharma industry, attending several events held by the Association of the British Pharmaceutical Industry (ABPI), including its annual conference in May, 2011.

15th October 2012

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics